Syntel, Inc. : A rebound is expected near USD 88.7
Entry price | Target | Stop-loss | Potential |
---|
US$91.85 |
US$96.8 |
US$84.8 |
+5.39% |
---|
Syntel, the outsourcing company which provides information technology and outsourcing consulting services, has seen its share decline during the last trading sessions.
The company shows strong fundamentals. Sales are expected to grow by 13% for a net income of 225 in 2014. Analysts consensus on Syntel remains buyer. Indeed, its revisions on EPS progressed by 15% in the last 12 months for the 2014 fiscal year. Moreover, “Superformance” trading rating is highly encouraging for long position taking since the business is highly predictable and profitable.
Technically, the stock is in the middle of a downtrend. This negative movement toward the USD 88.7 level should continue through ensuing sessions, allowing investors to profit from an interesting entry point. For now, daily moving averages are helping the stock path in its way to lower prices, but once the support tested weekly moving averages would assist for a upturn. Hence, the target price will be fixed at USD 96 for a stop loss order placed below the entry point at USD 84.8.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.